Fig. 4From: Immune-related histologic phenotype in pretreatment tumour biopsy predicts the efficacy of neoadjuvant anti-PD-1 treatment in squamous lung cancerImmune infiltration and the expression of PD-L1 in different response regions. CD3 and CD163 showed infiltrated CD3+ T cells and histocytes. cPR, complete pathologic response; pPR, partial pathologic response; nPR, no pathologic response; LNMCa, lymph node metastatic carcinoma; PD-L1, programmed cell death ligand-1Back to article page